Baseclick and Tebubio Join Forces to Revolutionize Nucleic Acid Bioconjugation and labeling

Computer-generated image

Symbolic image

This partnership represents a significant milestone in advancing the field of nucleic acid bioconjugation and labeling, providing researchers with unprecedented access to cutting-edge tools and solutions. With baseclick's expertise in click chemistry and Tebubio's extensive portfolio of high-quality reagents, the collaboration aims to provide scientists with tailored solutions for precise and efficient nucleic acid modification.

"We are excited to partner with Tebubio to bring our innovative nucleic acid labeling technologies and products to researchers in France," said Dr. Thomas Frischmuth CEO of Baseclick. "This collaboration underscores our commitment advancing scientific discovery by providing researchers with the tools they need."

baseclick's portfolio of nucleic acid labelling solutions complements Tebubio's extensive experience in life science research, enabling researchers to leverage a wide range of applications such as PCR, in situ hybridisation, RNA/DNA detection and more.

Romain Goulay (CSO, Tebubio) says “We’re pleased to welcome baseclick as a partner of Tebubio and look forward to providing researchers throughout Europe and the UK access to these exciting new labeling technologies.”

Other news from the department business & finance

Most read news

More news from our other portals

Fighting cancer: latest developments and advances